NPM1 and cancer: The fifth protein was B23/NPM1, which was identified as a major target of CIGB-300 in cancer cells, but also, as a relevant target for antiviral therapies (Lobaina and Perera 2019, Nouri et al. 2015, Perera et al. 2009).